Bülent BOYACI, Serkan ÜNLÜ, Abdurrahman TUFAN, Azmi EYİOL, Çağrı YAYLA, Mustafa CEMRİ, Rıdvan YALÇIN

Relationship of serum HLA-B alleles and TNF-α with rheumatic heart disease

Background/aim: Acute rheumatic fever and rheumatic heart disease are major causes of morbidity and mortality in developingcountries. Genetic studies have determined that the immune response in rheumatic heart disease is genetically controlled and that thereis a close relationship between the gene of concern and the class II human leukocyte antigen (HLA) gene. The aim of this study was toevaluate the relationship of serum HLA-B alleles and tumor necrosis factor alpha (TNF-α) with rheumatic heart disease.Materials and methods: A total of 50 consecutive patients with rheumatic heart disease and 50 controls were enrolled in the study. HLAalleles were analyzed using sequence-specific primer-polymerase chain reaction and nucleotide sequencing.Results: The HLA-B35 allele was significantly more common in patients with rheumatic heart disease than the control group (P =0.043). The HLA-B44 allele was significantly more common in control patients than in patients with rheumatic heart disease (P = 0.014).There was a significant inverse correlation between high-sensitivity C-reactive protein and mitral valve area (P = 0.001). There was nocorrelation between TNF-α levels and mitral valve area (P = 0.066).Conclusion: Our findings confirmed the association between HLA-B alleles and rheumatic heart disease.

PDF

___

Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005; 366: 155-168.
Rabuş M, Demirbağ R, Sezen Y, Taşar M, Taşkın A, Aksoy N, Kirali K, Yakut C. Serum prolidase activity in patients with degenerative and rheumatic heart valve diseases. Turk J Med Sci 2010; 40: 687-692.
Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Kalil J. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 1991; 83: 1995-1998.
Cassidy JT, Petty RE. Textbook of Pediatric Rheumatology. 2nd ed. Philadelphia, PA, USA: Churchill Livingstone; 1990. pp. 571-585.
Goldsmith DP. Poststreptococcal rheumatic manifestations: an ongoing tale. J Clin Rheumatol 2010; 16: 1-2.
Guedez Y, Kotby A, El-Demellawy M, Galal A, Thomson G, Zaher S, Kassem S, Kotb M. HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 1999; 99: 2784-2790.
Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451-2496.
Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
Gibofsky A, Zabriskie JB. Rheumatic fever: new insights into an old disease. Bull Rheum Dis 1993; 42: 5-7.
Bowness P. HLA B27 in health and disease: a double-edged sword? Rheumatology (Oxford) 2002; 41: 857-868.
DiSciascio G, Taranta A. Rheumatic fever in children. Am Heart J 1980; 99: 635-658.
Pickles W. Rheumatic fever. Lancet 1943; 2: 241-244.
Toor D, Leal K, Kumar R, Sharma YP, Chakraborti A. Association of HLA-DRB1*14 with rheumatic heart disease patients from Chandigarh, North India. Biomarkers 2012; 17: 160-165.
Ayoub EM, Barrett DJ, Maclaren NK, Krischer JP. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 1986; 77: 2019-2026.
Anastasiou-Nana MI, Anderson JL, Carlquist JF, Nanas JN. HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors. Am Heart J 1986; 112: 992-997.
Ahmed S, Ayoub EM, Scornik JC, Wang CY, She JX. Poststreptococcal reactive arthritis: clinical characteristics and association with HLA-DR alleles. Arthritis Rheum 1998; 41: 1096-1102.
Maharaj B, Hammond MG, Appadoo B, Leary WP, Pudifin DJ. HLA-A, B, DR, and DQ antigens in black patients with severe chronic rheumatic heart disease. Circulation 1987; 76: 259- 261.
Maharaj B, Khedun SM, Hammond MG, van der Byl K. HLA-A, B, DR, and DQ antigens in Indian patients with severe chronic rheumatic heart disease. Jpn Heart J 1997; 38: 663-668.
Ozkan M, Carin M, Sonmez G, Senocak M, Ozdemir M, Yakut C. HLA antigens in Turkish race with rheumatic heart disease [see comment]. Circulation 1993; 87: 1974-1978.
Karakurt C, Celiloğlu C, Özgen Ü, Yeşilada E, Yoloğlu S, Zabriskie J, Koçak G. Presence of a D8/17 B lymphocyte marker and HLA-DR subgroups in patients with rheumatic heart disease. Anadolu Kardiyol Der 2011; 11: 314-318.
Olmez U, Turgay M, Ozenirler S, Tutkak H, Duzgun N, Duman M, Tokgoz G. Association of HLA class I and class II antigens with rheumatic fever in a Turkish population. Scand J Rheumatol 1993; 22: 49-52.
Hallioglu O, Mesci L, Ozer S. DRB1, DQA1, DQB1 genes in Turkish children with rheumatic fever. Clin Exp Rheumatol 2005; 23: 117-120.
Guilherme L, Ramasawmy R, Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol 2007; 66: 199-207.
Burrows JM, Bell MJ, Brennan R, Miles JJ, Khanna R, Burrows SR. Preferential binding of unusually long peptides to MHC class I and its influence on the selection of target peptides for T cell recognition. Mol Immunol 2008; 45: 1818-1824.
Eastham RD, Szekely P, Davison K. C-reactive protein rheumatic heart disease. Ann Rheum Dis 1958; 17: 314-318.
Chiu-Braga YY, Hayashi SY, Schafranski M, Messias-Reason IJ. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hsCRP). Int J Cardiol 2006; 109: 275-276.
Karpuz D, Giray D, Ozyurt A, Bozlu G, Unal S, Hallioglu O. Can whole-blood parameters be used in follow-up of children with rheumatic valvular heart disease? Cardiol Young 2017; 27: 764-769.
Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003; 66: 1403-1408.
Yegin O, Coskun M, Ertug H. Cytokines in acute rheumatic fever. Eur J Pediatr 1997; 156: 25-29.
Berdeli A, Tabel Y, Celik HA, Ozyürek R, Dogrusoz B, Aydin HH. Lack of association between TNFα gene polymorphism at position -308 and risk of acute rheumatic fever in Turkish patients. Scand J Rheumatol 2006; 35: 44-47.